Embolic Protection Devices Market Size - By Product (Distal Occlusion Systems, Proximal Occlusion Systems, Distal Filters), By Application (Cardiovascular Disease, Neurovascular Disease, Peripheral Disease), By Material (Nitinol, Polyurethane), By End-use - Global Forecast, 2023 - 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationEmbolic Protection Devices Market Size - By Product (Distal Occlusion Systems, Proximal Occlusion Systems, Distal Filters), By Application (Cardiovascular Disease, Neurovascular Disease, Peripheral Disease), By Material (Nitinol, Polyurethane), By End-use - Global Forecast, 2023 - 2032
Embolic Protection Devices Market Size
Embolic Protection Devices Market was worth USD 1.4 billion in 2022. Driven by the increasing number of cardiovascular diseases (CVDs) globally, the industry is estimated to witness over 8.5% CAGR between 2023 and 2032. According to the WHO, CVDs are the leading cause of death globally, accounting for 17.9 million deaths in 2022.
The growing number of patients suffering from cardiac problems is fueling the need for percutaneous coronary interventions and the subsequent rise in demand for interventional cardiology & peripheral vascular devices. As per CDC, coronary artery disease is the most prevalent kind of heart disease in the U.S. The growing prevalence of CAD is contributing to rising product demand. Additionally, embolic protection devices provide the most effective, evidence-based method for decreasing significant adverse cardiovascular events and periprocedural myocardial infarction during SVG procedures, which will favor their adoption through 2032.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Embolic Protection Devices Market Size in 2022 | USD 1.4 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 8.6% |
| 2032 Value Projection | USD 3.1 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 210 |
| Tables, Charts & Figures | 349 |
| Segments covered | Product, Application, Material, End-use, & Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Embolic Protection Devices Market Growth Drivers & Restraints
The market is poised to gain significant momentum attributed to the favorable reimbursement scenario across American nations and the introduction of new advanced embolic protection devices. However, the availability of cheaper alternatives to embolic protection devices may lead to sluggish growth. Besides, the high cost of these devices may adversely impact product adoption rate since healthcare professionals in developing nations prefer inexpensive medical equipment.
COVID-19 Impact
The COVID-19 pandemic posed significant obstacles to PCI protocols. A remarkable surge in COVID-19 infections led to a considerable decline in percutaneous coronary intervention operations and peripheral interventions. According to the European Heart Journal, the number of cardiac surgeries in the UK registered a shortfall of more than 45,000 procedures due to the pandemic. Furthermore, logistical delays caused by lockdowns and delayed production activities impacted the product supply chain, resulting in temporary shortages and slowing down the market expansion.
Embolic Protection Devices Market Trends
Technological improvements and breakthroughs in embolic protection devices are expected to boost the business outlook over the next ten years. Distal occlusion devices, distal filter devices, and proximal occlusion/flow-reversal devices, among other innovations, are intended to avoid embolic debris during endovascular operations. For instance, Medtronic's Mo. Ma Ultra proximal cerebral protection device uses a double-occlusion balloon system to guarantee proximal embolic protection before passing a carotid lesion. Furthermore, continuous R&D targeted at enhancing the efficacy, safety, and ease of use of these devices will contribute to their increased acceptance.
Embolic Protection Devices Market Analysis
The embolic protection devices market from distal filters segment is projected to reach USD 1.9 billion by 2032, depicting over 8.5% CAGR from 2023 to 2032. The availability of a wide range of specifications and the surging usage of distal filters are driving industry expansion. The fundamental advantage of using distal filters versus proximal occlusion devices is that they keep blood flowing while capturing big material. Furthermore, such filters retain an antegrade circulation of blood and are simple to use, thus, propelling market revenue.
Over $540 million was made in 2022 from the sale of embolic protection devices, which are used to treat heart disease. This number is expected to jump to $1.3 billion by 2032. More people are getting heart disease, which is why this part of the market is growing. The Centers for Disease Control and Prevention (CDC) says that heart disease is one of the leading causes of death in the United States, with someone dying from it every 33 seconds. As more people look for non-invasive ways to treat these diseases, the need for effective heart devices that can lower the risk of complications will grow. As more embolic protection devices are used in transcatheter aortic valve replacement, percutaneous coronary intervention, and other heart procedures, there will be more demand for them.
North America has a big slice of the pie when it comes to the market for devices that help protect people from strokes and brain damage. In 2022, it accounted for more than 35% of all the money spent on these devices globally, and that number is expected to grow to a whopping $1 billion by 2032. This growth is being fueled by a couple of thingsfirst, there's been a rise in heart and brain diseases in the region. Second, big companies in this industry have a strong presence there. And let's not forget the growing number of people who are overweight or obese and have unhealthy lifestyles. According to Harvard, nearly 70% of adults in the U.S. are either overweight or obese. But that's not all. Companies are also constantly coming up with new and better embolic protection devices. This is all good news for the North American market, as it's expected to grow significantly over the next decade.
Embolic Protection Devices Market Share
Some of the major players operating in the embolic protection devices market are
- Transverse Medical, Inc.
- Abbott Laboratories
- Cardinal Health
- Allium Medica
- Edwards Lifesciences Corporation
- W. L. Gore & Associates (Gore Medical)
- Contego Medical, LLC
- Keystone Heart
- Medtronic
- Metactive Medical
- Boston Scientific Corporation
- Innovative Cardiovascular Solutions, LLC.
Embolic Protection Devices Market News
- In September 2022, Boston Scientific Corporation revealed the results from the clinical trial conducted on the PROTECTED TAVR for assessing the SENTINEL Cerebral Protection System, designed to capture and eliminate embolic debris from the replacement of the transcatheter aortic valve before it can reach the brain and potentially cause a stroke. Such advancements helped to retain the company's brand image while also extending the company's customer portfolio.
Embolic protection devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Product (USD Million)
- Distal occlusion systems
- Proximal occlusion systems
- Distal filters
By Application (USD Million)
- Cardiovascular disease
- Neurovascular disease
- Peripheral disease
By Material (USD Million)
- Nitinol
- Polyurethane
By End-use (USD Million)
- Hospitals
- Ambulatory surgical centers
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- The Netherlands
- Denmark
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Vietnam
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy